A drug which could help up to a million people in the UK who suffer from type 2 diabetes may soon be available on the NHS.
In final draft guidance, the National Institute for Health and Care Excellence (Nice) recommends the use of dapagliflozin for some people who suffer from the blood sugar condition.
The new drug, also known as forxiga, blocks the re-absorption of glucose in the kidneys and "promotes" excretion of excess glucose.
Manufacturers Bristol-Myers Squibb and AstraZeneca estimate that as many as one million patients could benefit from the drug.
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereComments are closed on this article